Ochsner Health COVID-19 SharePoint Site "Safety On Site" Click here to enter an S.O.S.
Medications listed are available on OH EPIC Formulary, unless otherwise noted.
Not all formulary medications are available at each facility. Please refer to your local pharmacy for available inventory.
Search results for:

daratumumab-hyaluronidase

daratumumab-hyaluronidase
Drug Name Form Strength Infusion Center Available Restricted Non-formulary Ambulatory Available Interchange REMS
Darzalex Faspro SOLUTION, SUBCUTANEOUS 1800 mg-30,000 units/15 mL        

High Alert Drug : Policy

Additional Information and Links

Restricted: to Outpatient Infusion Centers

Can be used as an alternative to daratumumab infusion, only for approved FDA indications for subcutaneous administration; daratumumab infusion not required for first does; required 6 hour observation time for first dose.


Last updated: May. 12, 2021


This site is intended for the staff of Ochsner Health. While others may view accessible pages, Ochsner Health makes no warranty, express or implied, as to the use of this information outside of Ochsner Health.